Landscapes / Targets

mTOR

16 drugs act on mTOR, in 25 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs16

DrugHow it worksCompanyStageNext dateDetails
Kinase inhibitor
Approved Jan 2028Phase 1/2 trial completes
—
Approved in EU 1 Feb 2028Phase 3 trial completes
—
Approved in other Dec 2030Phase 4 trial completes
—
Approved in EU —
RaparoBellnot checked
—
On the market —
—
Phase 3 Aug 2027Phase 2 trial completes
—
Phase 3 30 Sep 2029Phase 3 trial completes
—
Phase 2 Dec 2026Phase 2 trial completes
—
Phase 2 31 Dec 2026Phase 2 trial completes
—
Phase 2 1 Sep 2027Phase 2 trial completes
—
Phase 1/2 15 Oct 2027Phase 1/2 trial completes
—
Phase 2 Dec 2027Phase 2 trial completes
—
Faeth Therapeutics +1
Phase 2 Sep 2028Phase 2 trial completes
—
Phase 1/2 1 Sep 2030Phase 1/2 trial completes
—
AstraZeneca · Public AZN
Phase 2 —
—
Phase 1 —

About this list

Checked
15 of 16 drugs. The other 1 is marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow MTOR

Following is part of Solo: you see every change to MTOR the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in